Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jul 26, 2019
Date Accepted: Mar 30, 2020

The final, peer-reviewed published version of this preprint can be found here:

Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review

Li YC, Poly TN, Islam MM, Yang HC

Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review

JMIR Med Inform 2020;8(7):e15653

DOI: 10.2196/15653

PMID: 32706721

PMCID: 7400042

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Evaluation of Appropriateness of Overridden Alerts in Computerized Physician Order Entry: A Systematic Review

  • Yu-Chuan(Jack) Li; 
  • Tahmina Nasrin Poly; 
  • Md. Mohaimenul Islam; 
  • Hsuan Chia Yang

ABSTRACT

Background:

Clinical decision support system (CDSS) has been appeared as an indispensable tool for reducing medication errors and adverse drug events. A significant amount of studies reported that medication-related alerts in the current CDSS were often inappropriately overridden. Increased overridden rate has already raised questions about the appropriateness of CDSS application and raised a concern about the patient’s safety and quality of care.

Objective:

We, therefore, aim to conduct a systematic review to determine the overridden rate, the reasons for the alerts override and evaluate the appropriateness of overrides reasons.

Methods:

Systematic articles search of Google Scholar, PubMed, Embase, Scopus, Web of Science without language restrictions between January 1, 2000, and March 31, 2019. Two authors independently extracted data and cross-checked to avoid errors. Finally, the quality of the included studies was examined following the Cochrane guidelines.

Results:

A total of 23 articles were included in our systematic review. The rage of average override alerts was 46.2% to 96.2%. However, the rage of the overall appropriateness rate for override was 29.4% ~ 100%. Although, the rage of appropriateness was varied by alert types (Drug-allergy: 63.4%~ 100%, drug-drug interaction: 0%~95%, dose: 43.9%~88.8%, geriatric:14.3%~57%, renal: 27%~87.5%. Indeed, the interrater reliability for the assessment of override alerts appropriateness was excellent (the range of κ was 0.79~0.97). The most common reasons for override were “will monitor”, “patients have tolerated before”.

Conclusions:

The findings of our study show that CDSS overridden rate was often high and most of the cases overrides were identified as appropriate but the rate of appropriateness varied widely by different types of alerts. However, inappropriate overrides were associated with a higher rate of potential ADEs when compared with appropriate overrides. Future efforts should try to focus on reducing alert fatigue by providing alerts that are clinically relevant, information related alerts are clear and unambiguous.


 Citation

Please cite as:

Li YC, Poly TN, Islam MM, Yang HC

Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review

JMIR Med Inform 2020;8(7):e15653

DOI: 10.2196/15653

PMID: 32706721

PMCID: 7400042

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.